Maria Shepherd to Moderate Panel at J&J Depuy Synthes meeting October 5, 2016 in Raynham, MA
HBA Boston is pleased to announce its first ever meeting at J&J in Raynham on October 5, 2016. Attached is the brochure, and below is the link to sign up.
The event is a panel titled Changes in Healthcare – How Industry and Hospitals Can Win in the Transition From Volume to Value.
This panel will engage discussion between hospital administration, medtech, and pharma leaders about how we can work together in the new healthcare paradigm. It features three great panelists:
Christina Farup, MD: Vice President, evidence based medicine, DePuy Synthes (a Johnson and Johnson Company).
Leigh Anne Leas, PhD: Vice President and US Head, health policy, Novartis.
Beth Greenspan: Senior Vice President and Chief Strategy Officer, New England Baptist Hospital.
The transition from volume (fee-for-service) to value (fee for patient outcomes or the entire episode of care) has occurred in response to rising healthcare costs and is aimed at improving patient outcomes. This transformation of the volume-based model (example: pre-surgical imaging, surgery, post-surgical rehab) to an integrated, patient-outcomes model requires all parties to be responsible for patient improvement. This evolution will require defining measurements of “success,” integration of care delivery systems and affect all involved in healthcare. A panel of medical device, pharma and hospital leaders will discuss how healthcare and industry/hospital collaborations will be impacted by these changes.
Questions: As leaders in the healthcare industry,
– What can we do to demonstrate real value to all parties in the system?
– What are our common goals, with a focus on patient care?
– How do we overcome mistrust between Industry and Providers?
– How might industry research and innovation be impacted?
– What new skills do our organizations need to build to be successful during this time of change?